Group 6 Copy 235
0
    Please wait...

    About This Project

    The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Vision for the future: Understanding perceptual strategies following visual loss

    Many people will experience a decline in vision at some point in their life. For many people, this may be...

    Can we biologically extend the range of human vision into the near infrared?

    We have developed a protocol to augment human sight to see into the near infrared range through human formation...

    Assessing the pathogens of wild mammals in Los Angeles County

    Urban wildlife can harbor and transmit many diseases that have the potential to affect humans, domestic...

    Backer Badge Funded